Advanced COPD patients under home mechanical ventilation and/or long term oxygen therapy: Italian healthcare costs

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 75, Issue 4, 2011, Pages 207-214

  Vitacca, Michele ^a   Bianchi, L ^a   Bazza, A ^a   Clini, E M ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Home mechanical ventilation; Hypercapnia; Hypoxemia; Long term care programs

Indexed keywords

ANTIBIOTIC AGENT; STEROID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG COST; EMERGENCY CARE; FEE; FEMALE; HEALTH CARE COST; HOME CARE; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; ITALY; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OXYGEN THERAPY; PHYSICIAN; PNEUMONIA; PROSPECTIVE STUDY; RELAPSE; STEROID THERAPY; WARD; CONSULTATION; CONTROLLED STUDY; ITALIAN (CITIZEN); MEDICAL FEE;

EID: 84857622386     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2011.208     Document Type: Article

References (31)

1. Mannino DM, Buist S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-73. (Pubitemid 47321908)
2. Dal Negro R, Rossi A, Carver I. The burden of COPD in Italy: results from the Confronting COPD survey. Respir Med 2003; 97 Suppl C: S43-50. (Pubitemid 36266869)
3. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005; 25: 1025-31. (Pubitemid 40823777)
4. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 288-97.
5. Clini EM, Ambrosino N. Nonpharmacological treatment and relief of symptoms in COPD. Eur Respir J 2008; 32: 218-28.
6. Lynn J. Perspectives on care at the close of life serving patients who may die soon and their families: the role of hospice and other services. JAMA 2001; 285: 925-32. (Pubitemid 32171554)
7. Teno JM, Weitzen S, Fennell ML, Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med 2001; 4: 457-64. (Pubitemid 34027657)
8. Andersson FL, Svensson K, Gerhardsson de Verdier M. Hospital use for COPD patients during the last few years of their life. Respir Med 2006; 100: 1436-41. (Pubitemid 43964489)
9. Larson JL, Ahijevych K, Gift A, et al. ATS Nursing Research Priorities Subcommittee. American Thoracic Society statement on research priorities in respiratory nursing. Am J Respir Crit Care Med 2006; 174: 471-8. (Pubitemid 44223129)
10. Ambrosino N, Simonds A. The clinical management in extremely severe COPD. Respir Med 2007; 101: 1613-24. (Pubitemid 46947873)
11. Pinnock H, Kendall M, Murray SA, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ 2011; 342: d142. doi: 10.1136/bmj.d142.
12. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J 2008; 32: 796-03.
13. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-9.
14. Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD. A 1-year follow-up study. Chest 2003; 123: 784-91. (Pubitemid 36315494)
15. Nielsen R, Johannessen A, Benediktsdottir B, et al. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J 2009; 34: 850-7.
16. Koleva D, Motterlini N, Banfi P, Garattini L. Healthcare costs of COPD in Italian referral centres: A prospective study. Respir Med 2007; 101: 2312-20. (Pubitemid 47495743)
17. Halpin DM. Health Economics of Chronic Obstructive Pulmonary Disease. Proceedings of the ATS 2006; 3: 227-33. (Pubitemid 43668186)
18. Lucioni C, Donner CF, De Benedetto F, et al. I costi della broncopneumopatia cronica ostruttiva: la fase prospettica dello Studio ICE (Italian Costs for Exacerbations in COPD). Pharmacoeconomics - Italian Research Articles 2005; 7; 119-34.
19. Tynan AJ, Lane SJ. COPD: illness severity, resource utilisation and cost. Ir Med J 2005; 98: 41-4.
20. Detournay B, Pribil C, Fournier M, et al. The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health 2004; 7: 168-74. (Pubitemid 38420729)
21. Skrepnek GH, Skrepnek SV. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 2004; 10: s129-38. (Pubitemid 38970249)
22. Nishimura S, Zaher C. Cost impact of COPD in Japan: opportunities and challenges? Respirology 2004; 9: 466-73. (Pubitemid 40179751)
23. Masa JF, Sobradillo V, Villasante C, et al. Costs of chronic obstructive pulmonary disease in Spain: estimation from a population-based study. Arch Broncopneumol 2004: 40: 72-9. (Pubitemid 38339278)
24. Miravitlles M, Murio C, Guerrero T, et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121: 1449-55. (Pubitemid 34499654)
25. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2000; 118: 1278-85.
26. Rutten van Molken MP, Feenstra TL. The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands. Pharmacoeconomics 2001; 19 (Suppl 2): 1-6. (Pubitemid 32955059)
27. Jansson SA, Andersson F, Borg S, Ericsson A, Jönsson E, Lundbäck B. Costs of COPD in Sweden according to disease severity. Chest 2002; 122: 1994-02.
28. Halpern MT, Stanford RH, Borker R. The burden of COPD in the U.S.A.: results from the Confronting COPD survey. Respir Med 2003; 97 (Suppl C): S81-89. (Pubitemid 36266873)
29. Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of chronic obstructive pulmonary disease (COPD) in Italy: The SIRIO study (Social Impact of Respiratory Integrated Outcomes). Respir Med 2008; 102: 92-01.
30. Dal NR, Eandi M, Pradelli L, Iannazzo S. Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients. Int J Chron Obstruct Pulmon Dis 2007; 2: 169-76. (Pubitemid 47202217)
31. Clini EM, Magni G, Crisafulli E, Viaggi S, Ambrosino N. Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: comparison of costs. Respiration 2009; 77: 44-50.